JPMA to Vet Impact of Drug Pricing Reform, Make Proposals for R&D Tax Break System: FY2020 Project Plan

April 8, 2020
The Japan Pharmaceutical Manufacturers Association (JPMA) announced its FY2020 project plan on April 6, which calls for evaluating the impact of this year’s drug pricing reform in order to formulate a proposal of its own for the next reform scheduled...read more